Kutatási jelek – Signal Engine

• Current and future immunotherapeutic approaches in pancreatic cancer treatment — Pancreatic cancer
• ‘Amazing’ trial shows drug combination stops lung cancer advancing for longer — NSCLC
• Atezolizumab Combo Real-World Data Match Clinical Trial Efficacy in SCLC | CancerNetwork — SCLC
• CEPHEUS Highlights Efficacious, Safe Regimen for Transplant‑Ineligible/Deferred Multiple Myeloma — Multiple myeloma
• Discovery suggests opportunity to improve effectiveness of KRAS inhibitors against pancreatic cancer — Pancreatic cancer
• Foundational technology to make cancer cells revert to normal cells? — Colorectal cancer
• Ivonescimab Monotherapy Demonstrates Statistically Significant Overall Survival Benefit Compared to Pembrolizumab Monotherapy in PD-L1-Positive Advanced NSCLC in HARMONi-2 Study Conducted by Akeso in China — NSCLC
• Elironrasib Receives FDA Breakthrough Therapy Designation for Pretreated KRAS G12C+ NSCLC — NSCLC
• Ruxolitinib is Under Investigation as a JAK Inhibition Strategy for Multiple Myeloma — Thyroid cancer
• Systemic Therapy for Stage I-III Anal Squamous Cell Carcinoma: ASCO Guideline — Anal squamous cell carcinoma
• Neoadjuvant chemo-immunotherapy with camrelizumab plus nab-paclitaxel and cisplatin in resectable locally advanced squamous cell carcinoma of the head and neck: a pilot phase II trial — Head and neck squamous cell carcinoma
• Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review of the last decade — Malignant pleural mesothelioma
• Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma — Multiple myeloma
• Targeting CD30 in Diffuse Large B‑Cell Lymphoma: Where Does It Fit in? — Diffuse large B-cell lymphoma
• Head and Neck Cancer Clinical Benefit and Safety of Reduced Elective Dose in Definitive Radiotherapy for Head and Neck Squamous Cell Carcinoma: The UPGRADE-RT Multicenter Randomized Controlled Trial — Head and neck squamous cell carcinoma
• Evidence of being cured for nasopharyngeal carcinoma: results of a multicenter patient-based study in China — Nasopharyngeal carcinoma
• Recent advances in early detection of nasopharyngeal carcinoma — Nasopharyngeal carcinoma
• Safety and efficacy of pemigatinib in patients with cholangiocarcinoma: a systematic review — Cholangiocarcinoma
• Deeper response predicts better outcomes in high-risk smoldering multiple myeloma: results of the I-PRISM phase II clinical trial — Multiple myeloma
• GLP-1RA Use and Thyroid Cancer Risk — Thyroid cancer